The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.
about
Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patientsIFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in CaucasiansRevisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.Response-guided therapy for hepatitis C genotype 2 and 3 in those with HIV coinfection.You're not the one: treating subjects co-infected with hepatitis C genotypes 2 and 3 and human immunodeficiency virus.Genetic Association Studies in Host-Pathogen Interaction Analysis.
P2860
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The impact of interleukin 28B ...... n HIV/HCV-coinfected patients.
@en
The impact of interleukin 28B ...... n HIV/HCV-coinfected patients.
@nl
type
label
The impact of interleukin 28B ...... n HIV/HCV-coinfected patients.
@en
The impact of interleukin 28B ...... n HIV/HCV-coinfected patients.
@nl
prefLabel
The impact of interleukin 28B ...... n HIV/HCV-coinfected patients.
@en
The impact of interleukin 28B ...... n HIV/HCV-coinfected patients.
@nl
P2093
P50
P1433
P1476
The impact of interleukin 28B ...... in HIV/HCV-coinfected patients
@en
P2093
Axel Baumgarten
Berit A Payer
Christoph Boesecke
Dirk Meyer-Olson
Massimo Puoti
Michael Trauner
Robert Zangerle
P304
P356
10.1097/01.AIDS.0000432460.44593.EF
P407
P50
P577
2013-11-01T00:00:00Z